Felicia HeimerSenior Director, Rare Disease Compliance at Amgen and Co-Author of OIG's Practical Guidance for Health Care Governing Boards on Compliance OversightSpeaker
Agenda Sessions
From Compliance Leader to Board Member: Elevating Your Strategic Impact
, 2:15pmView Session
